Mass spectrometry based analysis of human plasma-derived factor X revealed novel post-translational modifications

Protein Science

Volumn 24, Issue 10, 2015, Pages 1640-1648

  Chevreux, Guillaume ^a   Tilly, Nolwenn ^a   Faid, Valegh ^a   Bihoreau, Nicolas ^a  

^a LFB Biotechnologies   (France)

Author keywords

coagulation factor X; mass spectrometry; O glucosylation; O glycosylation; phosphorylation

Indexed keywords

BLOOD CLOTTING FACTOR 10; GALACTOSE; GLUCOSE; GLYCAN; MANNOSE; PROTEIN C; SIALIC ACID; TRYPSIN; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; ELECTROSPRAY MASS SPECTROMETRY; GLYCOSYLATION; HEAVY CHAIN; HUMAN; HYDROLYSIS; HYDROPHOBICITY; HYDROXYLATION; LIGHT CHAIN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PEPTIDE ANALYSIS; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; SULFATION; TANDEM MASS SPECTROMETRY; CHEMISTRY; METABOLISM;

FACTOR X; HUMANS; MASS SPECTROMETRY; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84956892759     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2756     Document Type: Article

References (32)

1. Hertzberg M, (1994) Biochemistry of factor X. Blood Rev 8: 56-62.
2. Leytus SP, Foster DC, Kurachi K, Davie EW, (1986) Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry 25: 5098-5102.
3. Hansson K, Stenflo J, (2005) Post-translational modifications in proteins involved in blood coagulation. J Thromb Haemost 3: 2633-2648.
4. Fernlund P, Stenflo J, (1983) Beta-hydroxyaspartic acid in vitamin K-dependent proteins. J Biol Chem 258: 12509-12512.
5. McMullen BA, Fujikawa K, Kisiel W, Sasagawa T, Howald WN, Kwa EY, Weinstein B, (1983) Complete amino acid sequence of the light chain of human blood coagulation factor X: evidence for identification of residue 63 as beta-hydroxyaspartic acid. Biochemistry 22: 2875-2884.
6. Nishimura H, Kawabata S, Kisiel W, Hase S, Ikenaka T, Takao T, Shimonishi Y, Iwanaga S, (1989) Identification of a disaccharide (Xyl-Glc) and a trisaccharide (Xyl2-Glc) O-glycosidically linked to a serine residue in the first epidermal growth factor-like domain of human factors VII and IX and protein Z and bovine protein Z. J Biol Chem 264: 20320-20325.
7. Kuraya N, Hase S, (1992) Release of O-linked sugar chains from glycoproteins with anhydrous hydrazine and pyridylamination of the sugar chains with improved reaction conditions. J Biochem 112: 122-126.
8. Hase S, Nishimura H, Kawabata S, Iwanaga S, Ikenaka T, (1990) The structure of (xylose)2glucose-O-serine 53 found in the first epidermal growth factor-like domain of bovine blood clotting factor IX. J Biol Chem 265: 1858-1861.
9. Hase S, Kawabata S, Nishimura H, Takeya H, Sueyoshi T, Miyata T, Iwanaga S, Takao T, Shimonishi Y, Ikenaka T, (1988) A new trisaccharide sugar chain linked to a serine residue in bovine blood coagulation factors VII and IX. J Biochem 104: 867-868.
10. Titani K, Fujikawa K, Enfield DL, Ericsson LH, Walsh KA, Neurath H, (1975) Bovine factor X1 (Stuart factor): amino-acid sequence of heavy chain. Proc Natl Acad Sci USA 72: 3082-3086.
11. Nakagawa H, Takahashi N, Fujikawa K, Kawamura Y, Iino M, Takeya H, Ogawa H, Suzuki K, (1995) Identification of the oligosaccharide structures of human coagulation factor X activation peptide at each glycosylation site. Glycoconj J 12: 173-181.
12. Inoue K, Morita T, (1993) Identification of O-linked oligosaccharide chains in the activation peptides of blood coagulation factor X. The role of the carbohydrate moieties in the activation of factor X. Eur J Biochem 218: 153-163.
13. Yang L, Manithody C, Rezaie AR, (2009) Functional role of O-linked and N-linked glycosylation sites present on the activation peptide of factor X. J Thromb Haemost 7: 1696-1702.
14. Sinha U, Wolf DL, (1993) Carbohydrate residues modulate the activation of coagulation factor X. J Biol Chem 268: 3048-3051.
15. Camire RM, (2012) Bioengineered factor Xa as a potential new strategy for hemophilia therapy. Expert Rev Hematol 5: 121-123.
16. Wuhrer M, Catalina MI, Deelder AM, Hokke CH, (2007) Glycoproteomics based on tandem mass spectrometry of glycopeptides. J Chromatogr B Anal Technol Biomed Life Sci 849: 115-128.
17. Drakenberg T, Fernlund P, Roepstorff P, Stenflo J, (1983) beta-Hydroxyaspartic acid in vitamin K-dependent protein C. Proc Natl Acad Sci USA 80: 1802-1806.
18. Blom N, Gammeltoft S, Brunak S, (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294: 1351-1362.
19. Iwanaga S, Nishimura H, Kawabata S, Kisiel W, Hase S, Ikenaka T, (1990) A new trisaccharide sugar chain linked to a serine residue in the first EGF-like domain of clotting factors VII and IX and protein Z. Adv Exp Med Biol 281: 121-131.
20. Moloney DJ, Shair LH, Lu FM, Xia J, Locke R, Matta KL, Haltiwanger RS, (2000) Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules. J Biol Chem 275: 9604-9611.
21. Ishimizu T, Sano K, Uchida T, Teshima H, Omichi K, Hojo H, Nakahara Y, Hase S, (2007) Purification and substrate specificity of UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase involved in the biosynthesis of the Xyl alpha1-3Xyl alpha1-3Glc beta1-O-Ser on epidermal growth factor-like domains. J Biochem 141: 593-600.
22. Morita T, Jackson CM, (1986) Localization of the structural difference between bovine blood coagulation factors X1 and X2 to tyrosine 18 in the activation peptide. J Biol Chem 261: 4008-4014.
23. Miletich JP, Jackson CM, Majerus PW, (1978) Properties of the factor Xa binding site on human platelets. J Biol Chem 253: 6908-6916.
24. Di Scipio RG, Hermodson MA, Yates SG, Davie EW, (1977) A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry 16: 698-706.
25. Huttner WB, (1988) Tyrosine sulfation and the secretory pathway. Annu Rev Physiol 50: 363-376.
26. White G, Shapiro A, Ragni M, Garzone P, Goodfellow J, Tubridy K, Courter S, (1998) Clinical evaluation of recombinant factor IX. Semin Hematol 35: 33-38.
27. Rand MD, Kalafatis M, Mann KG, (1994) Platelet coagulation factor Va: the major secretory platelet phosphoprotein. Blood 83: 2180-2190.
28. Kalafatis M, Rand MD, Mann KG, (1994) The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269: 31869-31880.
29. Kalafatis M, Rand MD, Jenny RJ, Ehrlich YH, Mann KG, (1993) Phosphorylation of factor Va and factor VIIIa by activated platelets. Blood 81: 704-719.
30. Yoshida A, Suzuki M, Ikenaga H, Takeuchi M, (1997) Discovery of the shortest sequence motif for high level mucin-type O-glycosylation. J Biol Chem 272: 16884-16888.
31. Vosseller K, Trinidad JC, Chalkley RJ, Specht CG, Thalhammer A, Lynn AJ, Snedecor JO, Guan S, Medzihradszky KF, Maltby DA, Schoepfer R, Burlingame AL, (2006) O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry. Mol Cell Proteomics 5: 923-934.
32. Harazono A, Kobayashi T, Kawasaki N, Itoh S, Tada M, Hashii N, Ishii A, Arato T, Yanagihara S, Yagi Y, Koga A, Tsuda Y, Kimura M, Sakita M, Kitamura S, Yamaguchi H, Mimura H, Murata Y, Hamazume Y, Sato T, Natsuka S, Kakehi K, Kinoshita M, Watanabe S, Yamaguchi T, (2011) A comparative study of monosaccharide composition analysis as a carbohydrate test for biopharmaceuticals. Biologicals 39: 171-180.